Literature DB >> 1663083

Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis.

D E Griswold1, E F Webb, L M Hillegass.   

Abstract

Leukotriene induction of the fluid and cellular phases of the inflammatory response in the mouse was evaluated. Intraperitoneal injection of leukotriene C4 (LTC4 250 ng) led to dye extravasation but not polymorphonuclear leukocyte (PMN) infiltration, whereas injection of leukotriene B4 (LTB4 250 ng), led to PMN infiltration but not dye extravasation. The injection of both leukotrienes did not result in synergy. LTC4 did not appear to induce significant release or formation of chemotactic mediators, but the dye extravasation induced by LTC4 was inhibited by the vasoactive amine antagonist cyproheptadine and not by the eicosanoid inhibitors phenidone or naproxen. The response was markedly inhibited by the cytokine and eicosanoid inhibitors SK&F 86002 and SK&F 104493. PMN infiltration induced by LTB4 was not inhibited by SK&F 86002 or phenidone but was abrogated by colchicine treatment. LTB4 in this model did not appear to cause release or formation of vasoactive mediators. These leukotrienes appeared to be independent, complementary, and sufficient to mount a complete inflammatory response in the mouse.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663083     DOI: 10.1007/bf00917310

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  17 in total

Review 1.  The neutrophil and leukotrienes--role in health and disease.

Authors:  W König; W Schönfeld; M Raulf; M Köller; J Knöller; J Scheffer; J Brom
Journal:  Eicosanoids       Date:  1990

2.  Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a.

Authors:  C R Suarez; W C Pickett; D H Bell; D K McClintock; A L Oronsky; S S Kerwar
Journal:  J Rheumatol       Date:  1987-02       Impact factor: 4.666

Review 3.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

4.  Prostaglandins as potentiators of increased vascular permeability in inflammation.

Authors:  T J Williams; J Morley
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

5.  Adjuvant-induced arthritis in rats. II. Drug effects on physiologic, biochemical and immunologic parameters.

Authors:  D T Walz; M J DiMartino; A Misher
Journal:  J Pharmacol Exp Ther       Date:  1971-07       Impact factor: 4.030

Review 6.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

7.  Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response.

Authors:  R A Kreisle; C W Parker; G L Griffin; R M Senior; W F Stenson
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

8.  Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. Prostaglandin- and leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor.

Authors:  T J Sayers; T A Wiltrout; C A Bull; A C Denn; A M Pilaro; B Lokesh
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

9.  Phlogistic activity of leukotriene D4 in the mouse.

Authors:  D E Griswold; E F Webb; M A Clark; S Mong
Journal:  Inflammation       Date:  1986-03       Impact factor: 4.092

10.  Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.

Authors:  R P Carlson; L O'Neill-Davis; J Chang; A J Lewis
Journal:  Agents Actions       Date:  1985-12
View more
  10 in total

1.  Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.

Authors:  Nguyen Dang Hung; Mee Ree Kim; Dai-Eun Sok
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

2.  High-affinity pan-specific monoclonal antibodies that target cysteinyl leukotrienes and show efficacy in an acute model of colitis.

Authors:  Ashlee N King; Jonathan K Fleming; Stephanie S Knapik; Barbara Visentin; Jonathan M Wojciak; Tom Huxford
Journal:  J Lipid Res       Date:  2017-05-15       Impact factor: 5.922

3.  Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.

Authors:  H J Showell; R Breslow; M J Conklyn; G P Hingorani; K Koch
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.

Authors:  A Maekawa; Y Kanaoka; B K Lam; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 5.  The role of the LTB4-BLT1 axis in chemotactic gradient sensing and directed leukocyte migration.

Authors:  Bhagawat C Subramanian; Ritankar Majumdar; Carole A Parent
Journal:  Semin Immunol       Date:  2017-10       Impact factor: 11.130

6.  Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1alpha (MIP-1alpha), monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice.

Authors:  U Deiters; P F Mühlradt
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory.

Authors:  Long Shuang Huang; Nguyen Dang Hung; Dai-Eun Sok; Mee Ree Kim
Journal:  Lipids       Date:  2010-02-18       Impact factor: 1.880

8.  Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.

Authors:  D E Griswold; E F Webb; J Breton; J R White; P J Marshall; T J Torphy
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

9.  Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.

Authors:  C Zuany-Amorim; D Leduc; B B Vargaftig; M Pretolani
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress.

Authors:  M Spite; L Summers; T F Porter; S Srivastava; A Bhatnagar; C N Serhan
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.